Walgreens Boots Alliance Inc. WBA, -1.22% said Monday that it removed restrictions on purchases of over-the-counter children’s cold medications. The pharmacy retail giant in December limited purchases of fever-reducing medicines during a surge in pediatric cases of respiratory syncytial virus, flu, and COVID-19 that began in the fall. Walgreens’ stock is down 33.1% over the past year, while the broader S&P 500 SPX, -0.20% has declined 14.1%.
This article was originally published by Marketwatch.com. Read the original article here.
